Bucked Up RUT is generally tolerable for healthy adults in the short term, but it carries several ingredient-specific safety concerns that are worth understanding before you take it. None of its individual ingredients have caused widespread harm in clinical trials at standard doses, yet some have limited human safety data, and the product itself has not been third-party tested for purity.
What’s in RUT
The formula contains Vitamin D3 (125 mcg), folate (400 mcg), zinc (30 mg), KSM-66 ashwagandha (750 mg), tribulus terrestris extract (750 mg), tongkat ali, and DIM (diindolylmethane). The product page does not list specific dosages for tongkat ali or DIM, which makes it harder to evaluate their safety on a per-serving basis. There is no iron in the formula, so iron overload is not a concern here.
These ingredients fall into two categories: well-studied vitamins and minerals (D3, folate, zinc) and herbal extracts with varying levels of clinical evidence. The vitamins and zinc are at reasonable doses. The zinc sits at the tolerable upper intake level for adults (40 mg/day), so if you’re also getting zinc from a multivitamin or fortified foods, you could exceed that threshold and experience nausea or reduced copper absorption over time.
Ashwagandha: The Liver and Thyroid Question
KSM-66 ashwagandha at 750 mg is one of the most common doses used in supplements, and most clinical trials report no serious side effects at this level. That said, the NIH’s LiverTox database now rates ashwagandha as a “likely cause of clinically apparent liver injury,” based on a growing number of case reports. The typical pattern involves cholestatic liver injury (meaning bile flow gets disrupted) appearing 2 to 12 weeks after starting the supplement, with jaundice and itching. Most cases resolved after stopping, but rare instances of fatal liver injury or the need for emergency liver transplant have been reported, particularly in people with preexisting liver disease.
Ashwagandha can also affect your thyroid. At least one documented case involved a healthy 32-year-old woman who developed symptoms of an overactive thyroid, including weight loss, shakiness, and heart palpitations, six weeks after starting ashwagandha. Her thyroid levels returned to normal after she stopped. If you have a thyroid condition or take thyroid medication, this ingredient is a real concern. The National Center for Complementary and Integrative Health specifically recommends against ashwagandha for people with thyroid or autoimmune disorders.
Tongkat Ali: Limited Long-Term Data
Tongkat ali is traditionally used at 100 to 400 mg daily. Many testosterone-boosting supplements, including products like RUT, use doses at or above this range. Side effects at conventional doses are uncommon but can include nausea, abdominal discomfort, diarrhea, headaches, and rash.
The bigger concern is what we don’t know. The effects of long-term use and higher doses have not been assessed in humans. The European Food Safety Authority has expressed concern that tongkat ali may cause DNA damage and concluded that its “safety has not been established under any condition of use.” That’s a notably cautious position from a regulatory body, and it means you’re essentially taking on unknown risk with extended use.
RUT Is Not Third-Party Certified
Bucked Up’s parent company, DAS Labs, does hold NSF certification for several of its pre-workout products. However, RUT is not on that certified list. NSF certification means a product has been independently tested to confirm it contains what the label says and is free of contaminants like heavy metals or banned substances. Without that certification, you’re relying entirely on the company’s internal quality control. This matters especially for herbal products, where contamination and mislabeling are well-documented problems across the supplement industry.
Medication Interactions
Several ingredients in RUT can interact with common medications. Ashwagandha may interfere with drugs for diabetes, high blood pressure, seizures, and thyroid conditions. It can also dampen the effectiveness of immunosuppressants and amplify the effects of sedatives. If you take any prescription medication, particularly in those categories, this product could create unpredictable interactions.
Ashwagandha is also not recommended for people about to undergo surgery, as it may affect blood pressure and sedation during anesthesia.
Prostate and Hormonal Risks
RUT is designed to support testosterone levels, and ashwagandha in particular has evidence of actually raising testosterone. That sounds like the point of the product, but it introduces a specific risk: people with hormone-sensitive prostate cancer should avoid ashwagandha entirely. The NCCIH states this directly.
More broadly, artificially elevated testosterone levels in men are associated with prostate enlargement, difficulty urinating, acne, fluid retention, mood swings, and sleep problems. Research on men using testosterone therapy found that prostate cancer was detected within two years of starting treatment in over half of the diagnosed cases. While RUT is a supplement and not hormone replacement therapy, the principle holds: pushing testosterone higher than your body’s natural set point carries risks, and your body’s feedback system may respond by reducing its own production.
Who Should Avoid RUT
- People with liver disease. The ashwagandha liver injury cases were most dangerous in those with preexisting liver conditions.
- People with thyroid disorders. Ashwagandha can push thyroid hormone levels into an overactive range.
- People on blood pressure, diabetes, seizure, or thyroid medications. Documented interactions exist with ashwagandha.
- People with prostate concerns. Any supplement designed to raise testosterone levels is a risk factor for hormone-sensitive prostate conditions.
- People taking immunosuppressants or sedatives. Ashwagandha can interfere with both drug categories.
For a healthy adult male with no preexisting conditions and no prescription medications, short-term use of RUT at the recommended dose is unlikely to cause serious harm. But “unlikely to cause serious harm” is different from “proven safe,” and the lack of third-party testing, the limited long-term data on tongkat ali, and the emerging liver safety signal for ashwagandha all add layers of uncertainty that are worth weighing honestly.